The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
Portfolio Pulse from
The Schall Law Firm is inviting shareholders with losses to join a securities fraud class action lawsuit against Applied Therapeutics, Inc. The lawsuit alleges violations of the Securities Exchange Act of 1934. Investors who purchased securities between January 3, 2024, and December 2, 2024, are encouraged to contact the firm by February 18, 2025.
February 14, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics, Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The lawsuit against Applied Therapeutics for alleged securities fraud is significant and could lead to negative investor sentiment, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100